Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
Adelstein DJ, Moon J, Hanna E, Giri PG, Mills GM, Wolf GT, Urba SG. Adelstein DJ, et al. Among authors: moon j. Head Neck. 2010 Feb;32(2):221-8. doi: 10.1002/hed.21179. Head Neck. 2010. PMID: 19557750 Free PMC article. Clinical Trial.
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH; Southwest Oncology Group, Head and Neck Working Group. Worden FP, et al. Among authors: moon j. Cancer. 2006 Jul 15;107(2):319-27. doi: 10.1002/cncr.21994. Cancer. 2006. PMID: 16779801 Free article. Clinical Trial.
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
Agrawal A, Moon J, Davis RK, Sakr WA, Giri SP, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE; Southwest Oncology Group. Agrawal A, et al. Among authors: moon j. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1044-50. doi: 10.1001/archotol.133.10.1044. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17938330 Clinical Trial.
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial.
Markman M, Liu PY, Moon J, Monk BJ, Copeland L, Wilczynski S, Alberts D. Markman M, et al. Among authors: moon j. Gynecol Oncol. 2009 Aug;114(2):195-8. doi: 10.1016/j.ygyno.2009.04.012. Epub 2009 May 17. Gynecol Oncol. 2009. PMID: 19447479 Free PMC article. Clinical Trial.
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. Yoo GH, et al. Among authors: moon j. Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19770418 Free PMC article. Clinical Trial.
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.
Arnold SM, Moon J, Williamson SK, Atkins JN, Ou SH, LeBlanc M, Urba SG. Arnold SM, et al. Among authors: moon j. Invest New Drugs. 2011 Apr;29(2):352-9. doi: 10.1007/s10637-009-9348-z. Epub 2009 Nov 25. Invest New Drugs. 2011. PMID: 19937365 Free PMC article. Clinical Trial.
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
Tiersten AD, Moon J, Smith HO, Wilczynski SP, Robinson WR 3rd, Markman M, Alberts DS. Tiersten AD, et al. Among authors: moon j. Oncology. 2009;77(6):395-9. doi: 10.1159/000279386. Epub 2010 Feb 2. Oncology. 2009. PMID: 20130422 Free PMC article.
8,091 results